Overview

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
0
Participant gender:
All
Summary
Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate the efficacy of S-Caine Peel for induction of local dermal anesthesia for PDL therapy in adults.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
ZARS Pharma Inc.
Treatments:
Lidocaine
Tetracaine
Criteria
Inclusion Criteria:

- Patient is 18 years of age or older

- Patient elects to undergo PDL therapy for the treatment of vascular lesions on the
face

Exclusion Criteria:

- Patient is pregnant or breastfeeding

- Patient has participated in a clinical trial of an unapproved drug within the previous
30 days

- Patient has participated in any clinical trial involving S-Caine Peel